{"nct_id":"NCT05265728","title":"A Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of Natalizumab (BG00002) Administered Subcutaneously to Japanese Participants With Relapsing-Remitting Multiple Sclerosis","status":"TERMINATED","status_verified_date":"2025-01","start_date":"2022-04-26","start_date_type":"ACTUAL","primary_completion_date":"2024-01-18","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BIIB"]}